InvestorsHub Logo
Followers 61
Posts 7545
Boards Moderated 2
Alias Born 02/10/2010

Re: jdheart101 post# 43584

Thursday, 11/16/2023 2:58:52 PM

Thursday, November 16, 2023 2:58:52 PM

Post# of 43810
A couple of weeks ago the share price was $2 or less. I'm guessing that $2 is what price that CVM could negotiate with whomever big-wig was willing to fork over that much operating capital. It's not the company's focus to maintain a particular share price for short-term traders or newly acquired shareholders looking for a quick score.

It's the company's focus to get Multikine to market, to start generating regular revenue on its own, or to attract interest from a big partner or buy-out pharma. To do that the company needed a sizable chunk of operating capital to keep moving forward. The price to the company for that new chunk of operating capital was a discount for the big investor who could provide that needed capital in the near term.

I bought some new shares this morning at around $2.30. Yeah, sure, they are down even a bit more since then, but I don't focus any money I invest in short-term gains/losses. When Multikine gains regulatory approval - be that in the EU, Great Britain, Canada or with the FDA - that resulting gain in share prices is going to be extremely substantial. Ditto with a buyout - if that's what ends up happening.

How does that recent Warren Buffett quote go: "The stock market is a device for transferring money from the impatient to the patient."

“The two most powerful warriors are patience and time.”
- Leo Nikolaevich Tolstoy

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News